Cell Signaling Technology, Inc. Announces PD-L1 Antibody, Important to Cancer ... Business Wire India (press release) CST's PD-L1 Rabbit mAb is an important addition for researchers studying tumor immunology and potential approaches to immunotherapy for melanoma, lung, ovarian, renal, prostate, and other cancers. Clinical researchers are evaluating antibodies to ... |
